Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Timothy SpelmanSerkan OzakbasRaed AlroughaniMurat TerziSuzanne HodgkinsonGuy LaureysTomas KalincikAnneke Van Der WaltBassem YamoutJeannette Lechner-ScottAysun SoysalJens KuhleJose Luis Sanchez-MenoyoYolanda Blanco MorgadoDaniele LA SpitaleriVincent van PeschDana HorákováRadek AmpapaFrancesco PattiRichard MacdonellAbdullah Al-AsmiOliver GerlachJiwon OhAyse AltintasNamita TundiaSchiffon L WongHelmut ButzkuevenPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Cladribine tablets were associated with a significantly greater real-world treatment persistence and more favorable relapse outcomes than all oral DMT comparators.
Keyphrases